Sensipar Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
Conditions: Primary Hyperparathyroidism; Parathyroid Adenoma; Parathyroid Hyperplasia Interventions: Drug: Cinacalcet 30 mg Tablet; Drug: Denosumab Inj 60 mg/ml; Other: Placebo tablets; Other: Saline Injection (Placebo) Sponsors: Peter Vestergaard; Aalborg University Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2017 Category: Research Source Type: clinical trials

Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism
Conditions: Hyperparathyroidism, Primary; OsteoporosisInterventions: Drug: cinacalcet; Drug: AlendronateSponsor: Istituto Auxologico ItalianoCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2015 Category: Research Source Type: clinical trials

Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients
Condition: Secondary HyperparathyroidismIntervention: Drug: Combination Cinacalcet with Vitamin D analogueSponsors: Penang Hospital, Malaysia; Ministry of Health, MalaysiaNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2015 Category: Research Source Type: clinical trials